HomeCompareGSGTF vs PG

GSGTF vs PG: Dividend Comparison 2026

GSGTF yields 1052.08% · PG yields 2.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GSGTF wins by $29376466.50M in total portfolio value
10 years
GSGTF
GSGTF
● Live price
1052.08%
Share price
$0.19
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29376466.55M
Annual income
$24,748,961,707,406.69
Full GSGTF calculator →
PG
Procter & Gamble
● Live price
2.92%
Share price
$144.73
Annual div
$4.23
5Y div CAGR
31.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.4K
Annual income
$9,955.44
Full PG calculator →

Portfolio growth — GSGTF vs PG

📍 GSGTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGSGTFPG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GSGTF + PG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GSGTF pays
PG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GSGTF
Annual income on $10K today (after 15% tax)
$89,426.62/yr
After 10yr DRIP, annual income (after tax)
$21,036,617,451,295.69/yr
PG
Annual income on $10K today (after 15% tax)
$248.27/yr
After 10yr DRIP, annual income (after tax)
$8,462.12/yr
At 15% tax rate, GSGTF beats the other by $21,036,617,442,833.56/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GSGTF + PG for your $10,000?

GSGTF: 50%PG: 50%
100% PG50/50100% GSGTF
Portfolio after 10yr
$14688233.30M
Annual income
$12,374,480,858,681.07/yr
Blended yield
84.25%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PG right now

GSGTF
No analyst data
Altman Z
-9.7
Piotroski
2/9
PG
Analyst Ratings
29
Buy
22
Hold
1
Sell
Consensus: Buy
Price Target
$167.67
+15.9% upside vs current
Range: $150.00 — $179.00
Altman Z
5.3
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GSGTF buys
0
PG buys
0
No recent congressional trades found for GSGTF or PG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGSGTFPG
Forward yield1052.08%2.92%
Annual dividend / share$2.00$4.23
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%31.1%
Portfolio after 10y$29376466.55M$51.4K
Annual income after 10y$24,748,961,707,406.69$9,955.44
Total dividends collected$29025351.72M$29.3K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: GSGTF vs PG ($10,000, DRIP)

YearGSGTF PortfolioGSGTF Income/yrPG PortfolioPG Income/yrGap
1← crossover$115,908$105,207.79$11,003$382.92+$104.9KGSGTF
2$1,263,685$1,139,663.68$12,205$520.11+$1.25MGSGTF
3$12,964,467$11,612,324.37$13,674$712.22+$12.95MGSGTF
4$125,211,982$111,340,001.64$15,507$985.02+$125.20MGSGTF
5$1,138,959,685$1,004,982,865.01$17,847$1,378.96+$1138.94MGSGTF
6$9,762,216,739$8,543,529,875.74$20,913$1,959.19+$9762.20MGSGTF
7$78,882,996,544$68,437,424,632.64$25,044$2,834.00+$78882.97MGSGTF
8$601,231,379,017$516,826,572,714.96$30,786$4,189.46+$601231.35MGSGTF
9$4,324,770,879,470$3,681,453,303,922.24$39,052$6,357.54+$4324770.84MGSGTF
10$29,376,466,548,439$24,748,961,707,406.69$51,429$9,955.44+$29376466.50MGSGTF

GSGTF vs PG: Complete Analysis 2026

GSGTFStock

GenSight Biologics S.A., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. The company develops its products through gene therapy-based mitochondrial targeting sequence and optogenetics technology platforms. Its lead product candidates include LUMEVOQ (GS010), a recombinant AAV2-based gene therapy, which is in Phase III clinical trials for the treatment of leber hereditary optic neuropathy caused by a mutated ND4 gene; and GS030, which is in Phase I/II clinical trial for the treatment of retinitis pigmentosa, as well as in preclinical stage to treat dry age-related macular degeneration. The company also develops products that are in preclinical stage targeting ophthalmic and neurodegenerative diseases. GenSight Biologics S.A. was incorporated in 2012 and is headquartered in Paris, France.

Full GSGTF Calculator →

PGConsumer Staples

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands. The Grooming segment provides shave care products and appliances under the Braun, Gillette, and Venus brand names. The Health Care segment offers toothbrushes, toothpastes, and other oral care products under the Crest and Oral-B brand names; and gastrointestinal, rapid diagnostics, respiratory, vitamins/minerals/supplements, pain relief, and other personal health care products under the Metamucil, Neurobion, Pepto-Bismol, and Vicks brands. The Fabric & Home Care segment provides fabric enhancers, laundry additives, and laundry detergents under the Ariel, Downy, Gain, and Tide brands; and air care, dish care, P&G professional, and surface care products under the Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer brands. The Baby, Feminine & Family Care segment offers baby wipes, taped diapers, and pants under the Luvs and Pampers brands; adult incontinence and feminine care products under the Always, Always Discreet, and Tampax brands; and paper towels, tissues, and toilet papers under the Bounty, Charmin, and Puffs brands. The company sells its products primarily through mass merchandisers, e-commerce, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, specialty beauty stores, high-frequency stores, pharmacies, electronics stores, and professional channels, as well as directly to consumers. The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.

Full PG Calculator →
📬

Get this GSGTF vs PG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GSGTF vs SCHDGSGTF vs JEPIGSGTF vs OGSGTF vs KOGSGTF vs MAINGSGTF vs KMBGSGTF vs CLGSGTF vs CHD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.